94 related articles for article (PubMed ID: 23497229)
1. Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.
Awab GR; Pukrittayakamee S; Jamornthanyawat N; Yamin F; Dondorp AM; Day NP; White NJ; Woodrow CJ; Imwong M
Malar J; 2013 Mar; 12():96. PubMed ID: 23497229
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.
Awab GR; Imwong M; Pukrittayakamee S; Alim F; Hanpithakpong W; Tarning J; Dondorp AM; Day NP; White NJ; Woodrow CJ
Malar J; 2016 Feb; 15():121. PubMed ID: 26917051
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.
Huang F; Tang L; Yang H; Zhou S; Liu H; Li J; Guo S
Malar J; 2012 Jul; 11():243. PubMed ID: 22839209
[TBL] [Abstract][Full Text] [Related]
4. Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia.
Mkulama MA; Chishimba S; Sikalima J; Rouse P; Thuma PE; Mharakurwa S
Malar J; 2008 May; 7():87. PubMed ID: 18495008
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy.
Amor A; Toro C; Fernández-Martínez A; Baquero M; Benito A; Berzosa P
Malar J; 2012 Mar; 11():100. PubMed ID: 22462737
[TBL] [Abstract][Full Text] [Related]
7. Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.
Alam MT; de Souza DK; Vinayak S; Griffing SM; Poe AC; Duah NO; Ghansah A; Asamoa K; Slutsker L; Wilson MD; Barnwell JW; Udhayakumar V; Koram KA
J Infect Dis; 2011 Jan; 203(2):220-7. PubMed ID: 21288822
[TBL] [Abstract][Full Text] [Related]
8. Characterization of drug resistance genes in Indian Plasmodium falciparum and Plasmodium vivax field isolates.
Narang G; Jakhan J; Tamang S; Yadav K; Singh V
Acta Trop; 2024 Jul; 255():107218. PubMed ID: 38636585
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh, India.
Singh A; Singh MP; Ali NA; Poriya R; Rajvanshi H; Nisar S; Bhandari S; Sahu RS; Jayswar H; Mishra AK; Das A; Kaur H; Anvikar AR; Escalante AA; Lal AA; Bharti PK
Malar J; 2023 Dec; 22(1):375. PubMed ID: 38072967
[TBL] [Abstract][Full Text] [Related]
10. Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia.
Asih PB; Rogers WO; Susanti AI; Rahmat A; Rozi IE; Kusumaningtyas MA; Krisin ; Sekartuti ; Dewi RM; Coutrier FN; Sutamihardja A; van der Ven AJ; Sauerwein RW; Syafruddin D
Malar J; 2009 Sep; 8():222. PubMed ID: 19788738
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016-2020: Clinical and genetic studies.
Adam M; Nahzat S; Kakar Q; Assada M; Witkowski B; Tag Eldin Elshafie A; Abuobaida D; Safi N; Khan MA; Nagi M; Mustafa SA; Kohestani K; Muhammad J; Khim N; Al-Hadi M; Elfaki TM; Habib MN; Khairy AKA; Hamid H; Uddin Z; Amer Y; Hassan AH; Elhag MS; Sediqi AW; Kakar I; Abdul-Ghani R; Amran JGH; Abdallrahim TA; Tamim MS; Aljasari A; Rasmussen C; Azkoul L; Warsame M
Trop Med Int Health; 2023 Oct; 28(10):817-829. PubMed ID: 37705047
[TBL] [Abstract][Full Text] [Related]
12.
Somé AF; Conrad MD; Kabré Z; Fofana A; Yerbanga RS; Bazié T; Neya C; Somé M; Kagambega TJ; Legac J; Garg S; Bailey JA; Ouédraogo J-B; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0153423. PubMed ID: 38411062
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis on Plasmodium falciparum sulfadoxine-pyrimethamine resistance-conferring mutations in India identifies hot spots for genetic surveillance.
Sinha A; Kar S; Chauhan C; Yadav CP; Kori L
Int J Antimicrob Agents; 2024 Mar; 63(3):107071. PubMed ID: 38154659
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial.
Allen EN; Little F; Camba T; Cassam Y; Raman J; Boulle A; Barnes KI
Malar J; 2009 Jun; 8():141. PubMed ID: 19558654
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of molecular markers for resistance to chloroquine and pyrimethamine in Plasmodium falciparum from Zimbabwe.
Mlambo G; Sullivan D; Mutambu SL; Soko W; Mbedzi J; Chivenga J; Gemperli A; Kumar N
Parasitol Res; 2007 Sep; 101(4):1147-51. PubMed ID: 17546463
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania.
Bwire GM; Ngasala B; Mikomangwa WP; Kilonzi M; Kamuhabwa AAR
Sci Rep; 2020 Feb; 10(1):3500. PubMed ID: 32103124
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.
Ravenhall M; Benavente ED; Mipando M; Jensen AT; Sutherland CJ; Roper C; Sepúlveda N; Kwiatkowski DP; Montgomery J; Phiri KS; Terlouw A; Craig A; Campino S; Ocholla H; Clark TG
Malar J; 2016 Nov; 15(1):575. PubMed ID: 27899115
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance profiling of asymptomatic and low-density Plasmodium falciparum malaria infections on Ngodhe island, Kenya, using custom dual-indexing next-generation sequencing.
Osborne A; Phelan JE; Kaneko A; Kagaya W; Chan C; Ngara M; Kongere J; Kita K; Gitaka J; Campino S; Clark TG
Sci Rep; 2023 Jul; 13(1):11416. PubMed ID: 37452073
[TBL] [Abstract][Full Text] [Related]
19. Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda.
Asua V; Conrad MD; Aydemir O; Duvalsaint M; Legac J; Duarte E; Tumwebaze P; Chin DM; Cooper RA; Yeka A; Kamya MR; Dorsey G; Nsobya SL; Bailey J; Rosenthal PJ
J Infect Dis; 2021 Mar; 223(6):985-994. PubMed ID: 33146722
[TBL] [Abstract][Full Text] [Related]
20. Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study.
Florimond C; de Laval F; Early AM; Sauthier S; Lazrek Y; Pelleau S; Monteiro WM; Agranier M; Taudon N; Morin F; Magris M; Lacerda MVG; Viana GMR; Herrera S; Adhin MR; Ferreira MU; Woodrow CJ; Awab GR; Cox H; Ade MP; Mosnier E; Djossou F; Neafsey DE; Ringwald P; Musset L
Lancet Infect Dis; 2024 Feb; 24(2):161-171. PubMed ID: 37858325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
